PuSH - Publikationsserver des Helmholtz Zentrums München

Export: TXT Text RIS Endnote (RIS) BIB BibTeX
Bohne, F. ; Londoño, M.C.* ; Benítez, C.* ; Miquel, R.* ; Martínez-Llordella, M.* ; Russo, C. ; Ortiz, C.* ; Bonaccorsi-Riani, E.* ; Brander, C.* ; Bauer, T. ; Protzer, U. ; Jaeckel, E.* ; Taubert, R.* ; Forns, X.* ; Navasa, M.* ; Berenguer, M.* ; Rimola, A.* ; Lozano, J.J.* ; Sánchez-Fueyo, A.*

HCV-induced immune responses influence the development of operational tolerance after liver transplantation in humans.

Sci. Transl. Med. 6:242ra81 (2014)
Verlagsversion Volltext DOI PMC
Closed
Open Access Green möglich sobald Postprint bei der ZB eingereicht worden ist.
Pathogen-induced immune responses prevent the establishment of transplantation tolerance in experimental animal models. Whether this occurs in humans as well remains unclear. The development of operational tolerance in liver transplant recipients with chronic hepatitis C virus (HCV) infection allows us to address this question. We conducted a clinical trial of immunosuppression withdrawal in HCV-infected adult liver recipients to elucidate (i) the mechanisms through which allograft tolerance can be established in the presence of an ongoing inflammatory response and (ii) whether anti-HCV heterologous immune responses influence this phenomenon. Of 34 enrolled liver recipients, drug withdrawal was successful in 17 patients (50%). Tolerance was associated with intrahepatic overexpression of type I interferon and immunoregulatory genes and with an expansion of exhausted PD1/CTLA4/2B4-positive HCV-specific circulating CD8(+) T cells. These findings were already present before immunosuppression was discontinued and were specific for HCV infection. In contrast, the magnitude of HCV-induced proinflammatory gene expression and the breadth of anti-HCV effector T cell responses did not influence drug withdrawal outcome. Our data suggest that in humans, persistent viral infections exert immunoregulatory effects that could contribute to the restraining of alloimmune responses, and do not necessarily preclude the development of allograft tolerance.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
14.414
3.027
60
60
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Schlagwörter Hepatitis-c Virus; Persistent Lcmv Infection; I Interferon; T-cells; Immunosuppression Withdrawal; Allograft-rejection; Viral-hepatitis; Cutting Edge; Recipients; Expression
Sprache englisch
Veröffentlichungsjahr 2014
HGF-Berichtsjahr 2014
ISSN (print) / ISBN 1946-6234
e-ISSN 1946-6242
Zeitschrift Science Translational Medicine
Quellenangaben Band: 6, Heft: 242, Seiten: , Artikelnummer: 242ra81 Supplement: ,
Verlag American Association for the Advancement of Science (AAAS)
Begutachtungsstatus Peer reviewed
Institut(e) Institute of Virology (VIRO)
Institute of Molecular Immunology (IMI)
POF Topic(s) 30203 - Molecular Targets and Therapies
30504 - Mechanisms of Genetic and Environmental Influences on Health and Disease
Forschungsfeld(er) Immune Response and Infection
PSP-Element(e) G-502700-002
G-502700-003
G-501790-002
PubMed ID 24964989
DOI 10.1126/scitranslmed.3008793
WOS ID WOS:000338711900003
Scopus ID 84903767450
Erfassungsdatum 2014-06-28
[➜Korrektur melden]